SV40 and Cancer Risk in Organ Transplant Patients
Author Information
Author(s): Paracchini V, Costa A, Nanni S, Garte S, Taioli E
Primary Institution: University of Pittsburgh Cancer Institute
Hypothesis
Does the presence of Simian Virus 40 (SV40) in organ donors increase cancer risk in transplant recipients?
Conclusion
Recipients of solid organs from SV40 positive donors do not have an increased risk of cancer after transplant.
Supporting Evidence
- None of the 41 recipients of organs from SV40 positive donors developed a tumour during the follow-up.
- 11 recipients of organs from SV40 negative donors developed a tumour.
- The average length of follow-up after transplant was 671 days.
Takeaway
This study looked at whether a virus called SV40 in organ donors makes transplant patients more likely to get cancer. It found that it doesn't.
Methodology
The study followed 387 organ transplant recipients for cancer development, comparing those who received organs from SV40 positive and negative donors.
Limitations
The follow-up period was relatively short, averaging 671 days.
Participant Demographics
The donors were Caucasian, 56.7% male, with an average age of 48 years.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website